Literature DB >> 14620598

Adverse drug reactions: types and treatment options.

Marc A Riedl1, Adrian M Casillas.   

Abstract

Drug hypersensitivity results from interactions between a pharmacologic agent and the human immune system. These types of reactions constitute only a small subset of all adverse drug reactions. Allergic reactions to medications represent a specific class of drug hypersensitivity reactions mediated by IgE. Immune-mediated drug reactions may be discussed generally in the Gell and Coombs classification system, a widely accepted conceptual framework for understanding complex immune reactions. However, some reactions involve additional, poorly understood mechanisms that are not easily classified. Identifiable risk factors for drug hypersensitivity reactions include age, female gender, concurrent illnesses, and previous hypersensitivity to related drugs. Drug hypersensitivity is a clinical diagnosis based on available data. Laboratory testing may be useful, with skin testing providing the greatest specificity. Treatment is largely supportive and includes discontinuation of the offending medication, symptomatic treatment, and patient education. Patients with penicillin allergy should avoid carbapenems, and caution should be used in prescribing cephalosporins in these patients. Reactions to radiocontrast media can be limited by pretreatment with prednisone, diphenhydramine, and either ephedrine or a histamine H2-receptor antagonist.

Entities:  

Mesh:

Year:  2003        PMID: 14620598

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  46 in total

1.  Drug Hypersensitivity Reactions Documented in Electronic Health Records within a Large Health System.

Authors:  Adrian Wong; Diane L Seger; Kenneth H Lai; Foster R Goss; Kimberly G Blumenthal; Li Zhou
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-01

2.  Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.

Authors:  Hamed Laroui; Duke Geem; Bo Xiao; Emilie Viennois; Poonam Rakhya; Timothy Denning; Didier Merlin
Journal:  Mol Ther       Date:  2013-09-12       Impact factor: 11.454

3.  Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn's Disease.

Authors:  Philip N Okafor; Francis A Farraye; Adetoro T Okafor; Daniel O Erim
Journal:  Dig Dis Sci       Date:  2015-07-16       Impact factor: 3.199

4.  Predictive value of the lymphocyte toxicity assay in the diagnosis of drug hypersensitivity syndrome.

Authors:  Abdelbaset A Elzagallaai; Zahra Jahedmotlagh; Blanca R Del Pozzo-Magaña; Sandra R Knowles; Asuri N Prasad; Neil H Shear; Michael J Rieder; Gideon Koren
Journal:  Mol Diagn Ther       Date:  2010-10-01       Impact factor: 4.074

5.  Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients.

Authors:  Gregory S Phillips; Azael Freites-Martinez; Meier Hsu; Anna Skripnik Lucas; Dulce M Barrios; Kathryn Ciccolini; Michael A Marchetti; Liang Deng; Patricia L Myskowski; Erica H Lee; Alina Markova; Mario E Lacouture
Journal:  J Am Acad Dermatol       Date:  2017-12-19       Impact factor: 11.527

Review 6.  A systematic review of utility values for chemotherapy-related adverse events.

Authors:  Fatiha H Shabaruddin; Li-Chia Chen; Rachel A Elliott; Katherine Payne
Journal:  Pharmacoeconomics       Date:  2013-04       Impact factor: 4.981

7.  Self-reported medication side effects in an older cohort living independently in the community--the Melbourne Longitudinal Study on Healthy Ageing (MELSHA): cross-sectional analysis of prevalence and risk factors.

Authors:  Jennifer A Thomson; Wei C Wang; Colette Browning; Hal L Kendig
Journal:  BMC Geriatr       Date:  2010-06-10       Impact factor: 3.921

8.  A pharmacovigilance study on patients of bronchial asthma in a teaching hospital.

Authors:  A N Jamali; M Aqil; M S Alam; K K Pillai; P Kapur
Journal:  J Pharm Bioallied Sci       Date:  2010-10

9.  Adverse drug reactions and deliberate self-poisoning as cause of admission to the intensive care unit: a 1-year prospective observational cohort study.

Authors:  Lukas Schwake; Ines Wollenschläger; Wolfgang Stremmel; Jens Encke
Journal:  Intensive Care Med       Date:  2008-08-12       Impact factor: 17.440

10.  Noncardiogenic pulmonary edema associated with clopidogrel: a serious but unexpected side effect of clopidogrel.

Authors:  Izzet Celal Erdinler; Ekrem Ucer; Abdurrahman Eksik; Ahmet Akyol; Selcuk Yazici
Journal:  Can J Cardiol       Date:  2007-05-01       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.